Tags
- 14th
- 4
- A
- Abstract
- Acro
- Across
- Adjustment
- Administration
- Adult
- Agonist
- An
- Analyse
- Analysis
- Association
- Baseline
- Beneficiary
- Clinical endpoint
- Cohort
- Cohort study
- College
- College of Medicine
- Conclusion
- Confidence
- Confidence interval
- Congratulations
- Consistency
- Cox
- Crude
- Crude incidence rate
- Data
- Diabetes
- Diabetes mellitus type 2
- Diagnosis
- Dipeptidyl peptidase
- Dipeptidyl peptidase-4
- Disease
- Drs Michael
- Drug
- Effect
- Employment
- Endpoint
- Estimate
- Evidence
- Florida
- GLD
- Glucagon-like peptide-1
- Glucagon-like peptide 1 receptor
- Hazard
- Hazard ratio
- Hazards
- Incidence
- Incidence rate
- Inhibitor
- Initiation
- Insulin
- Interval
- Intervals
- Inverse
- Inverse probability
- Lower risk
- Man-hour
- Medicare
- Medicare beneficiaries
- Medicine
- Melissa Armstrong
- Methods
- Michael Okun
- Model
- Molecule
- Neurology
- New
- No
- Normal distribution
- Obesity
- Observation
- Okun
- Old age
- Older
- Parkinson
- Parkinson's
- Parkinson’s disease
- Parkinson's disease
- Pd Wa
- Peptide
- Performance
- Primary
- Probability
- Proportional hazards model
- Proportionality
- Protease
- Publication
- Receptor
- Regression
- Remains
- Risk
- Secret Agent 077
- Sensor
- Sex
- Stabilizer
- Statistical significance
- Stratification
- Studie
- Subgroup
- T2D
- Total
- Type 2
- University
- University of Florida
- Weighting
- When
- Who